VIDO-InterVac: World class, leading-edge research

What VIDO-InterVac does best


Research excellence

  • VIDO-InterVac is a world leader in developing vaccines and technologies against infectious diseases.


  • Created in 1975, research collaborations have resulted in 80-plus U.S. patents and eight commercialized vaccines.  Six of these vaccines were world firsts. 



Protecting animals, Saving Lives

  • Our vaccines have saved millions of dollars for the agricultural industry, making Canada more competitive internationally and enhancing global trade.


  • Our research is driving the discovery of new vaccines that are transforming the future of public health.



Success through collaboration 

  • VIDO-InterVac is open to academic teams and researchers from Canadian and international universities, commercial partners, research institutes and governments.


  • Cutting-edge technology and facilities provide unparalleled opportunities for research.



The International Vaccine Centre (InterVac) is Canada's newest lab for protecting animals and humans against emerging infectious diseases:


  • The new $140 million InterVac facility addresses the international shortage of facilities for studying Containment Level 3 (CL3) pathogens using diverse animal models.


  • When InterVac becomes operational in 2013, it will be one of the largest and most advanced of its kind in North America.